Cassava Sciences Depreciation & Amortization 2011-2026 | SAVA

Annual Depreciation & Amortization Cassava Sciences

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
952 K	1.08 M	804 K	310 K	22 K	58 K	69 K	68 K	58 K	45 K	15 K	-	122 K	163 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.08 M	15 K	290 K

Quarterly Depreciation & Amortization Cassava Sciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
200 K	200 K	220 K	-	200 K	300 K	311 K	-	273 K	272 K	272 K	-	181 K	174 K	178 K	-	121 K	-	1 K	-	21 K	20 K	14 K	-	44 K	30 K	17 K	-	52 K	34 K	17 K	-	51 K	34 K	18 K	-	41 K	28 K	14 K	-	32 K	18 K	4 K	-	10 K	7 K	3 K	-	-	-	-	-	122 K	70 K	35 K	-	128 K	93 K	53 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
311 K	1 K	95.4 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Xeris Pharmaceuticals XERS	1.31 M	$ 6.03	-1.55 %	$ 885 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
UroGen Pharma Ltd. URGN	307 K	$ 19.2	-11.52 %	$ 554 M	Israel
uniQure N.V. QURE	14.8 M	$ 10.89	-30.36 %	$ 530 M	Niderland
GT Biopharma GTBP	4 K	$ 0.47	-2.41 %	$ 892 K	USA
AbCellera Biologics ABCL	18.4 M	$ 3.74	3.6 %	$ 1.12 B	Canada
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	13.6 M	$ 3.36	0.86 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	5.2 M	$ 29.16	-3.54 %	$ 1.69 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Alector ALEC	5.72 M	$ 2.19	-9.77 %	$ 226 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	238 K	$ 4.21	-2.32 %	$ 299 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	3.02 M	$ 13.98	1.27 %	$ 5.7 B	Irlanda
AbbVie ABBV	762 M	$ 233.57	0.64 %	$ 413 B	USA
Blueprint Medicines Corporation BPMC	16.3 M	-	-	$ 8.14 B	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
AIM ImmunoTech AIM	38 K	$ 0.8	-11.6 %	$ 38.5 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.83	5.37 %	$ 4.53 M	China
Apellis Pharmaceuticals APLS	1.56 M	$ 20.67	-1.38 %	$ 2.61 B	USA